<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1812">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04689464</url>
  </required_header>
  <id_info>
    <org_study_id>1120</org_study_id>
    <nct_id>NCT04689464</nct_id>
  </id_info>
  <brief_title>COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients</brief_title>
  <official_title>COVID19 and Psychological Health: a Cross Sectional Evaluation of the Risks of Anxiety and Depression Among Patients Diagnosed With Covid 19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alhasan Mujtaba Al-Mudhaffer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Basrah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, Iraq</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>AlFayhaa General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The covid-19 pandemic started to spread worldwide since December 2019. It promoted to an&#xD;
      exaggerated psychological stress and anxiety in humans due to the intolerable symptoms higher&#xD;
      than usual death of many infected patients. This study examines the corona related anxiety&#xD;
      and if there is need for drug intervention to treat this anxiety.&#xD;
&#xD;
      To answer these questions, a survey made to the hospitalized patients including sex, age,&#xD;
      educational level, Marital state, and a standardized questionnaires (GAD-7 and PHQ-9) which&#xD;
      has been validated and shown to possess good psychometric qualities in studies of&#xD;
      participants from multiple populations.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>depression</measure>
    <time_frame>at the time of acute infection, average of 1 month</time_frame>
    <description>Depression measured by Patient Health Questionnaire-9 (PHQ-9) scale. Scoring: 5-9 mild;10-14 moderate; 15-19 moderately severe; &gt;20 severe. Minimum 0 maximum 27 points</description>
  </primary_outcome>
  <primary_outcome>
    <measure>anxiety</measure>
    <time_frame>at the time of acute infection, average of 1 month</time_frame>
    <description>Anxiety measured by General Anxiety Disorder-7 (GAD-7) scale. Scoring:5-9 mild; 10-14 moderate; &gt;15 severe. Minimum 0, maximum 21 points</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Covid19</condition>
  <condition>Anxiety</condition>
  <condition>Depression</condition>
  <arm_group>
    <arm_group_label>mild covid</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate covid</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>severe covid</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients with covid19 diagnosed by their healthcare providers&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - patients with COVID19 willing to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  unwilling unable to read or interact with standardized questionnaire unconscious&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zainab N Abdul-nabi, M.Sc.</last_name>
    <role>Study Director</role>
    <affiliation>University of Basrah</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hiba Dawood, M.Sc.</last_name>
    <role>Study Director</role>
    <affiliation>University of Basrah</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Qussay N Almaliki, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>AlFayhaa teaching hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nadheera F Neamah</last_name>
    <role>Study Director</role>
    <affiliation>University of Basrah</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dania Zydoon</last_name>
    <role>Principal Investigator</role>
    <affiliation>Al-Sader teaching hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zainab Mahdi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Al-Mawani general hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alhasan M Al-Mudhaffer, BCPS</last_name>
    <phone>009647801601693</phone>
    <email>user11126@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>AlFayhaa Teaching hospital</name>
      <address>
        <city>Basra</city>
        <zip>99999</zip>
        <country>Iraq</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alhasan M Al-Mudhaffer, BCPS</last_name>
      <phone>009647801601693</phone>
      <email>user11126@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Qusay N AlMalikee, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Iraq</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 26, 2020</study_first_submitted>
  <study_first_submitted_qc>December 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 30, 2020</study_first_posted>
  <last_update_submitted>December 29, 2020</last_update_submitted>
  <last_update_submitted_qc>December 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>AlFayhaa General Hospital</investigator_affiliation>
    <investigator_full_name>Alhasan Mujtaba Al-Mudhaffer</investigator_full_name>
    <investigator_title>Clinical Pharmacy Specialist</investigator_title>
  </responsible_party>
  <keyword>COVID19</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

